Leadership Team
Management Team
Under the leadership of Chief Executive Officer, Mr. Jean-Jacques Bienaimé, BioMarin’s executive management team includes accomplished leaders with deep and broad executive experience. Supported by a staff of approximately 800 employees worldwide, BioMarin is focused on delivering first-to-market therapies to patients with rare genetic diseases.
| Jean-Jacques Bienaimé Chief Executive Officer |
Daniel P. Maher Senior Vice President, Product Development |
| Robert A. Baffi, Ph.D. Executive Vice President, Technical Operations |
Joshua A. Grass Senior Vice President, Corporate and Business Development |
| Henry J. Fuchs, M.D. Executive Vice President and Chief Medical Officer |
Philip Lo Scalzo Vice President, Corporate Compliance and Ethics |
| Dan Spiegelman Executive Vice President and Chief Financial Officer |
Ed Von Pervieux Vice President and Chief Information Officer |
| Jeff Ajer Senior Vice President and Chief Commercial Officer |
Mark Wood Senior Vice President, Human Resources and Corporate Affairs |
| G. Eric Davis Senior Vice President, General Counsel and Secretary |
Board of Directors
| Jean-Jacques Bienaimé Chief Executive Officer |
Pierre Lapalme Former President and Chief Executive Officer, Ethypharm, Inc., North America |
| Kenneth Bate 2,5 President and Chief Executive Officer, Archemix, Inc. |
V. Bryan Lawlis 5,8 President and Chief Executive Officer, Itero Biopharmaceuticals, Inc. |
| Michael Grey 5,8 Venture Partner, Pappas Ventures; President and Chief Executive Officer, Lumena Pharmaceuticals, Inc. |
Alan Lewis, Ph.D. 4,6 Chief Executive Officer and Director, Ambit Biosciences |
| Elaine
Heron 7,8 Chairman and Chief Executive Officer, Amplyx Pharmaceuticals, Inc. |
Richard
Meier 1,7 Executive Vice President and Chief Financial Officer, TeleFlex, Incorporated |
| William
Young 3,6 Venture Partner, Clarus Venture, San Francisco and Boston |
|
|
1 Chairman, Audit Committee 2 Chairman, Compensation Committee 3 Chairman, Corporate Governance and Nominating Committee 4 Chairman, Science and Technology Committee 5 Member, Audit Committee 6 Member, Compensation Committee 7 Member, Corporate Governance and Nominating Committee 8 Member, Science and Technology Committee |
|
Science Advisory Board
| Jeffrey Borer, M.D. Chief of Division of Cardiovascular Medicine Chair of Medicine SUNY Downstate Medical Center Brooklyn, New York |
Joseph Loscalzo, M.D., Ph.D. Chairman, Department of Medicine Brigham and Women's Hospital Hersey Professor of the Theory and Practice of Medicine Harvard Medical School Boston, Massachusetts |
| Raymond C. Stevens, Ph.D. Department of Integrative Structural and Computational Biology The Scripps Research Institute La Jolla, California |
Ronald G. Crystal, MD Chairman of Genetic Medicine The Bruce Webster Professor of Internal Medicine Weill Cornell Medical College New York, New York |
| Stephen L. Hauser, M.D. Chair of the Department of Neurology Robert A. Fishman Distinguished Professor University of California San Francisco San Francisco, California |
Larry J. Shapiro, M.D. Spencer T. and Ann W. Olin Distinguished Professor Executive Vice Chancellor for Medical Affairs and Dean Washington University School of Medicine St. Louis, Missouri |
| Alan Lewis, Ph.D. Chief Executive Officer and Director, Medistem, Inc. |
|
